Tag: Valuation

Browse our exclusive articles!

Arm targets $52B valuation in record-breaking Nasdaq IPO, UK

Arm aims for $52B valuation in record-breaking IPO, sparking excitement and setting a precedent for tech IPOs. Apple, Google, and Nvidia show interest.

Arm’s IPO Sees Strong Investor Demand, Valuation Climbs to $54.5B

Arm's IPO garners strong investor demand, achieving a valuation of $54.5 billion. The chip designer aims to expand beyond mobile and capitalize on growth opportunities in cloud computing and automotive sectors.

SoftBank-owned chip firm Arm lowers valuation and fundraising target

Softbank's Arm chip firm adjusts valuation and fundraising target for public listing, now aiming for $5-7 billion fundraising and $50-60 billion valuation.

Arm reportedly lowers targeted valuation for long-awaited IPO, seeking $50bn-$55bn, UK

Arm, the British chip designer, lowers targeted IPO valuation to $50-55 billion, attracting major industry players.

Databricks in Talks for Fresh Funding Round, Valuation Could Surpass $43B, US

Databricks, the big data software giant, is in talks with T. Rowe Price for additional funding that could push its valuation beyond $43 billion. Discover how Databricks revolutionizes big data analytics with its efficient software and robust security options.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img